Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Rabies Treatment Companies

Rabies treatment primarily involves post-exposure prophylaxis (PEP), which includes a series of rabies vaccinations and, in some cases, rabies immune globulin (RIG) administration. There are several pharmaceutical companies and organizations involved in the production and distribution of rabies vaccines and related treatments. It's important to note that as of my last knowledge update in January 2022, the landscape of these companies may have changed, and new developments may have occurred.

Rabies Treatment Key Companies

Latest Rabies Treatment Companies Update

Sanofi Pasteur's rabies monoclonal antibody program: In October 2023, Sanofi Pasteur announced the initiation of Phase 1 clinical trials for its novel rabies monoclonal antibody program. This potentially game-changing development aims to offer a long-acting, non-vaccine alternative for post-exposure prophylaxis (PEP).

New rabies immunoglobulin (RIG) formulations: Bavarian Nordic received EU approval for its Rabipur® P intramuscular/subcutaneous rabies immunoglobulin formulation in August 2023. This offers healthcare professionals new options for administering RIG, potentially improving accessibility and convenience.

List of Rabies Treatment Key Companies in the Market

Sanofi (France)

Merck & Co. Inc.

CSC Pharmaceuticals International

Pfizer (U.S.)

VBI Vaccines Inc. (U.S.)

Taj Pharmaceuticals Limited (India)

Bio Med Pvt. Ltd.

Bavarian Nordic(U.S.)

Solvay(U.S.)

Informa plc.(U.S.)

Rabies Treatment Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.